GY
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
DevaCell
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6650 Lusk Blvd Ste B105, San Diego, Cali...Phone Number
(858) 263-7127Website
www.devacell.comRevenue
<$5 MillionIndustry
About DevaCell
DevaCell specializes in synthetic vector-based platform technology, focusing on transformative therapeutic opportunities in oncology, gene therapy, and vaccines. Their lead program utilizes novel synthetic vectors for oncolytic viral therapy, aiming to enhance the immune system's ability to target and destroy tumor cells. The company's immunotherapeutics are designed to activate multiple arms of the immune system, potentially improving patient outcomes significantly. DevaCell's ONCoat technology offers advantages such as preventing viral neutralization and enabling repeat systemic delivery.Explore more
SIC Code 87,873NAICS Code 54,541Show moreDevaCell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to DevaCell
Compare insights from companies similar to DevaCell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
DevaCell Tech Stack
A closer look at the technologies used by DevaCell
Top Business Services Companies
Frequently Asked Questions Regarding DevaCell
Sign Up For FreeTo access detailed company insights
DevaCell specializes in synthetic vector-based platform technology, focusing on transformative therapeutic opportunities in oncology, gene therapy, and vaccines. Their lead program utilizes novel synthetic vectors for oncolytic viral therapy, aiming to enhance the immune system's ability to target and destroy tumor cells. The company's immunotherap... Read More
